Clinical Trial Update: Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial is evaluating an intensified conditioning regimen combining ruxolitinib and decitabine for patients with acute myeloid leukemia under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) | Phase 4 | Status: RECRUITING